ClinicalTrialsFinder
RecruitingNCT06814574

Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement - Single Center Experience

Sponsor

Deutsches Herzzentrum Muenchen

Enrollment

25 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

AV Block CompleteTricuspid Regurgitation (TR)

Summary

Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with av block complete and tricuspid regurgitation (tr). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Deutsches Herzzentrum München

München, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06814574

Related Trials

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

NCT075869954 locations

Efficacy of Early Rhythm Control in AF With TR Patients

NCT076070931 location

Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study

NCT076179741 location

DELINEATE-Prospective

NCT071977361 location

Robotic Transjugular Transcatheter Tricuspid Valve Replacement

NCT075161451 location